ORMDL3 rs7216389: Understanding Asthma Susceptibility Associations
The rs7216389 variant is a single-nucleotide polymorphism located within the ORMDL3 gene region on chromosome 17. It has been widely studied for its statistical association with childhood asthma susceptibility and altered immune responses to respiratory viruses.
What each genotype means
Lower childhood asthma risk
This genotype is associated with a lower statistical risk of developing childhood asthma compared to other variants. Research suggests this may be linked to differences in ORMDL3 gene expression, though individual health outcomes are influenced by many genetic and environmental factors.
This genotype is common in many populations, though exact frequencies vary significantly by ancestry.
Average asthma risk profile
Individuals with this genotype typically show an average statistical risk for childhood asthma. This variant is part of a genetic region known to influence immune responses, but it does not indicate a specific predisposition on its own.
This heterozygous genotype is frequently observed across diverse global populations.
Increased childhood asthma risk
This genotype is statistically associated with an increased risk of childhood asthma. The variant is linked to altered ORMDL3 expression and reduced interferon-beta responses to rhinovirus, which may contribute to asthma exacerbations; however, this is a complex trait and not a diagnostic indicator.
This genotype is found in a significant portion of the population, with prevalence varying by ethnic background.
What is rs7216389?
The rs7216389 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), located on chromosome 17q21. This region is a well-known "hotspot" in human genetics that contains several genes, including ORMDL3 and GSDMB. Because these genes are physically close to one another on the chromosome, they are often inherited together in blocks. When researchers identify an association between rs7216389 and a health trait, it is sometimes difficult to determine if the variant itself is directly causing the effect or if it is simply acting as a marker for a nearby functional change in a neighboring gene. Scientific studies have consistently identified this site as a point of interest in the context of respiratory health, particularly regarding how the body manages inflammation and airway sensitivity.
The Role of the ORMDL3 Gene
The ORMDL3 gene, which stands for orosomucoid-like 3, plays a critical role in regulating sphingolipid metabolism. Sphingolipids are essential components of cell membranes and act as signaling molecules that influence various cellular processes, including immune responses and calcium homeostasis. Research suggests that ORMDL3 acts as a negative regulator of serine palmitoyltransferase, the enzyme responsible for the first step in sphingolipid synthesis. When ORMDL3 expression is altered, it can disrupt the balance of these lipids, potentially leading to changes in how bronchial epithelial cells respond to environmental triggers. Elevated levels of ORMDL3 have been observed in the bronchial tissue of individuals with asthma, leading researchers to investigate how this gene contributes to airway remodeling and the thickening of bronchial walls.
Research and Evidence Strength
The evidence linking rs7216389 to asthma is considered moderate and has been replicated across several ethnically diverse populations. Multiple genome-wide association studies (GWAS) have highlighted this locus as a significant contributor to childhood asthma risk. Beyond general susceptibility, some research indicates that this variant may influence the body's interferon-beta response, which is a key part of the immune system's defense against rhinovirus—a common trigger for asthma exacerbations. While the statistical association is robust, the biological mechanisms are complex. It is important to note that genetic associations are not diagnostic; having a specific genotype does not guarantee the development of asthma, nor does the absence of the variant prevent it. Asthma is a multifactorial condition influenced by a combination of genetic, environmental, and lifestyle factors.
Population Frequency
The frequency of the T and C alleles for rs7216389 varies across different global populations. In many studies, the minor allele frequency is substantial, meaning the variant is relatively common rather than rare. Because this SNP is found in diverse ancestral groups, researchers have been able to confirm its association with asthma across different genetic backgrounds. However, specific frequency data can fluctuate depending on the population being studied, such as in American Indian or Chinese cohorts, where researchers have documented specific allele distributions to better understand local disease risk. Because population-specific data is highly variable, it is best to consult large-scale genomic databases like gnomAD for the most current and precise frequency estimates relevant to specific ancestral groups.
Interpreting Your Genetic Information
Understanding your genetic variants can be an educational experience, but it is important to maintain realistic expectations. Genetic data provides a snapshot of your biological predispositions, not a medical diagnosis. If you are concerned about asthma or respiratory health, the most effective approach is to discuss your symptoms, family history, and any genetic testing results with a qualified healthcare provider or a genetic counselor. They can help you interpret this information in the context of your overall health. Never use genetic information to make decisions about medications or treatments without professional medical guidance. If you have questions about how your genetics might influence your response to specific asthma therapies, consult your clinician or pharmacist, who can provide personalized advice based on your clinical history.
How common is this variant?
The rs7216389 variant is polymorphic across most human populations, with allele frequencies varying significantly by ancestry. For example, studies in American Indian populations have reported a minor allele frequency of approximately 39.6%.
Frequently asked questions
Does having the T/T genotype mean I will get asthma?
No. Genetic variants like rs7216389 are associated with a statistical increase in risk, but they do not cause asthma on their own. Asthma is a complex condition influenced by many genes and environmental factors.
Can I use this SNP to predict if my child will have asthma?
Genetic testing for this SNP is not a diagnostic tool for asthma. Clinical diagnosis is based on symptoms, lung function tests, and medical history, not on a single genetic variant.
What should I do if I have the T/T genotype?
If you are concerned about your respiratory health, you should focus on managing known environmental triggers and maintaining regular check-ups with your doctor. You do not need to take specific medical action based solely on this genotype.
Is ORMDL3 the only gene involved in asthma?
No. Asthma is a polygenic trait, meaning it is influenced by many different genes. ORMDL3 is just one of many genetic factors that researchers have identified as contributing to asthma susceptibility.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7216389?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29